The combined profits for the ten drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion) [in 2002]… Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself.
Dr Marcia Angell
Former editor-in-chief of the New England Journal of Medicine.
Senior Lecturer in the Department of Global Health and Social Medicine at Harvard Medical School.
Author of The Truth About the Drug Companies: How They Deceive Us and What to Do About It.